Ono Y, Hirabayashi S, Yamada S, Ohshima S, Kinukawa T, Matsuura O, Takeuchi N, Hattori R
Department of Urology, Komaki Shimin Hospital.
Nihon Hinyokika Gakkai Zasshi. 1990 Feb;81(2):221-4. doi: 10.5980/jpnjurol1989.81.221.
The long term results of 28 HLA 1-haploidentical donor kidney transplant recipients receiving preoperative lymphocyte deletion through thoracic duct drainage and low dose of steroid and azathioprine immunosuppressive treatment were presented. The number of removed lymphocytes was 129.9 +/- 38.1 x 10(9) (mean +/- SD) and the duration of thoracic duct drainage pretreatment was 35 +/- 4 days. Graft survival was 96% at 3 months through 2 years, 89% at 3 years and 84% at 5 years. Patient survival was 100% at 3 months through 2 years and 96% at 3 years through 5 years. Fifteen acute rejection crises were observed in 13 patients within the first 3 months postoperatively. There was no irreversible rejection in the first 3 months. Four chronic rejections were observed in 4 patients. Life-threatening infectious disease was observed in 5 patients, diabetes mellitus in 2 and cataract in 4. These results indicated that the reduction of the dose of steroid in post transplant period might have beneficial effects on the long term graft survival of HLA 1-haploidentical kidney transplant patients receiving TDD pretreatment and the conventional immunosuppressive treatment.
本文报告了28例接受术前经胸导管引流及低剂量类固醇和硫唑嘌呤免疫抑制治疗的HLA单倍型相合供肾移植受者的长期结果。清除的淋巴细胞数量为129.9±38.1×10⁹(平均值±标准差),胸导管引流预处理的持续时间为35±4天。术后3个月至2年移植物存活率为96%,3年时为89%,5年时为84%。患者存活率在术后3个月至2年为100%,3年至5年为96%。术后前3个月内,13例患者发生了15次急性排斥反应。前3个月内无不可逆排斥反应。4例患者发生了4次慢性排斥反应。5例患者出现危及生命的感染性疾病,2例出现糖尿病,4例出现白内障。这些结果表明,在接受TDD预处理和传统免疫抑制治疗的HLA单倍型相合肾移植患者中,移植后期减少类固醇剂量可能对移植物长期存活有有益影响。